RecruitingNot Applicable

The Effect of Virtual Reality Application Diagnosed With Myocardial Infarction

Turkey (Türkiye)50 participantsStarted 2026-07-10

Plain-language summary

This study was designed to investigate the effects of VR (virtual reality) glasses on vital signs and anxiety in conscious patients diagnosed with myocardial infarction and admitted to the cardiology intensive care unit.

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. The patient is in intensive care.
. The patient has been diagnosed with myocardial infarction.
. The patient is between 18 and 70 years old.
. The patient is conscious.
. The patient is oriented and cooperative.
. The patient volunteers to participate in the study.
. The patient is open to communication.
. The patient agrees to participate in the study.

Exclusion criteria

. The patient has a psychiatric disorder.
. The patient has any communication impairment.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Anxiety Level

Timeframe: Periprocedural

Vital Signs - Blood pressure measurements (SBP, DBP)

Timeframe: Periprocedural

Vital Signs- heart rate

Timeframe: Periprocedural

Vital Signs - respiratory rate per minute

Timeframe: Periprocedural

Trial details

NCT IDNCT07696390

SponsorYuzuncu Yil University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09-18

Contact for this trial

Yavuz Uren, Asst.Prof.

+905065961050 yavuzuren@yyu.edu.tr

View on ClinicalTrials.gov More Myocardial Infarction trials

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. The patient is in intensive care.
. The patient has been diagnosed with myocardial infarction.
. The patient is between 18 and 70 years old.
. The patient is conscious.
. The patient is oriented and cooperative.
. The patient volunteers to participate in the study.
. The patient is open to communication.
. The patient agrees to participate in the study.

Exclusion criteria

. The patient has a psychiatric disorder.
. The patient has any communication impairment.